Click for best price
Autologous Stem Cell NonStem Cell Based Therapies Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Autologous Stem Cell and Non-Stem Cell Based Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Stem Cell and Non-Stem Cell Based Therapies. This report contains market size and forecasts of Autologous Stem Cell and Non-Stem Cell Based Therapies in global, including the following market information:
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Autologous Stem Cell and Non-Stem Cell Based Therapies market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Autologous Stem Cell Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autologous Stem Cell and Non-Stem Cell Based Therapies include Fibrocell Science, Inc., Vericel Corporation, Dendreon Corporation (Sanpower Group), Caladrius Biosciences, Inc., BrainStorm Cell Therapeutics, Regeneus Ltd., Genzyme Corporation, Pluristem Therapeutics Inc and U.S. Stem Cell, Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autologous Stem Cell and Non-Stem Cell Based Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Segment Percentages, by Type, 2022 (%)
Autologous Stem Cell Therapy
Non-Stem Cell Therapy
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Segment Percentages, by Application, 2022 (%)
Cancer
Neurodegenerative Disorders
Cardiovascular Disease
Autoimmune Diseases
Others
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autologous Stem Cell and Non-Stem Cell Based Therapies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autologous Stem Cell and Non-Stem Cell Based Therapies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fibrocell Science, Inc.
Vericel Corporation
Dendreon Corporation (Sanpower Group)
Caladrius Biosciences, Inc.
BrainStorm Cell Therapeutics
Regeneus Ltd.
Genzyme Corporation
Pluristem Therapeutics Inc
U.S. Stem Cell, Inc
TiGenix (Takeda)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autologous Stem Cell and Non-Stem Cell Based Therapies, market overview.
Chapter 2: Global Autologous Stem Cell and Non-Stem Cell Based Therapies market size in revenue.
Chapter 3: Detailed analysis of Autologous Stem Cell and Non-Stem Cell Based Therapies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autologous Stem Cell and Non-Stem Cell Based Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Overall Market Size
2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size: 2022 VS 2029
2.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players in Global Market
3.2 Top Global Autologous Stem Cell and Non-Stem Cell Based Therapies Companies Ranked by Revenue
3.3 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue by Companies
3.4 Top 3 and Top 5 Autologous Stem Cell and Non-Stem Cell Based Therapies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Autologous Stem Cell and Non-Stem Cell Based Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autologous Stem Cell and Non-Stem Cell Based Therapies Players in Global Market
3.6.1 List of Global Tier 1 Autologous Stem Cell and Non-Stem Cell Based Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Autologous Stem Cell and Non-Stem Cell Based Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Markets, 2022 & 2029
4.1.2 Autologous Stem Cell Therapy
4.1.3 Non-Stem Cell Therapy
4.2 By Type - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue & Forecasts
4.2.1 By Type - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2023
4.2.2 By Type - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2024-2029
4.2.3 By Type - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Neurodegenerative Disorders
5.1.4 Cardiovascular Disease
5.1.5 Autoimmune Diseases
5.1.6 Others
5.2 By Application - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue & Forecasts
5.2.1 By Application - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2023
5.2.2 By Application - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2024-2029
5.2.3 By Application - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2022 & 2029
6.2 By Region - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue & Forecasts
6.2.1 By Region - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2023
6.2.2 By Region - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2024-2029
6.2.3 By Region - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2029
6.3.2 US Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.3.3 Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.3.4 Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2029
6.4.2 Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.4.3 France Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.4.4 U.K. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.4.5 Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.4.6 Russia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.4.7 Nordic Countries Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.4.8 Benelux Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2029
6.5.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.5.3 Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.5.4 South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.5.5 Southeast Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.5.6 India Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2029
6.6.2 Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.6.3 Argentina Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2029
6.7.2 Turkey Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.7.3 Israel Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.7.4 Saudi Arabia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
6.7.5 UAE Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, 2018-2029
7 Autologous Stem Cell and Non-Stem Cell Based Therapies Companies Profiles
7.1 Fibrocell Science, Inc.
7.1.1 Fibrocell Science, Inc. Company Summary
7.1.2 Fibrocell Science, Inc. Business Overview
7.1.3 Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.1.4 Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.1.5 Fibrocell Science, Inc. Key News & Latest Developments
7.2 Vericel Corporation
7.2.1 Vericel Corporation Company Summary
7.2.2 Vericel Corporation Business Overview
7.2.3 Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.2.4 Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.2.5 Vericel Corporation Key News & Latest Developments
7.3 Dendreon Corporation (Sanpower Group)
7.3.1 Dendreon Corporation (Sanpower Group) Company Summary
7.3.2 Dendreon Corporation (Sanpower Group) Business Overview
7.3.3 Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.3.4 Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.3.5 Dendreon Corporation (Sanpower Group) Key News & Latest Developments
7.4 Caladrius Biosciences, Inc.
7.4.1 Caladrius Biosciences, Inc. Company Summary
7.4.2 Caladrius Biosciences, Inc. Business Overview
7.4.3 Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.4.4 Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.4.5 Caladrius Biosciences, Inc. Key News & Latest Developments
7.5 BrainStorm Cell Therapeutics
7.5.1 BrainStorm Cell Therapeutics Company Summary
7.5.2 BrainStorm Cell Therapeutics Business Overview
7.5.3 BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.5.4 BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.5.5 BrainStorm Cell Therapeutics Key News & Latest Developments
7.6 Regeneus Ltd.
7.6.1 Regeneus Ltd. Company Summary
7.6.2 Regeneus Ltd. Business Overview
7.6.3 Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.6.4 Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.6.5 Regeneus Ltd. Key News & Latest Developments
7.7 Genzyme Corporation
7.7.1 Genzyme Corporation Company Summary
7.7.2 Genzyme Corporation Business Overview
7.7.3 Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.7.4 Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.7.5 Genzyme Corporation Key News & Latest Developments
7.8 Pluristem Therapeutics Inc
7.8.1 Pluristem Therapeutics Inc Company Summary
7.8.2 Pluristem Therapeutics Inc Business Overview
7.8.3 Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.8.4 Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.8.5 Pluristem Therapeutics Inc Key News & Latest Developments
7.9 U.S. Stem Cell, Inc
7.9.1 U.S. Stem Cell, Inc Company Summary
7.9.2 U.S. Stem Cell, Inc Business Overview
7.9.3 U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.9.4 U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.9.5 U.S. Stem Cell, Inc Key News & Latest Developments
7.10 TiGenix (Takeda)
7.10.1 TiGenix (Takeda) Company Summary
7.10.2 TiGenix (Takeda) Business Overview
7.10.3 TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Major Product Offerings
7.10.4 TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global Market (2018-2023)
7.10.5 TiGenix (Takeda) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Opportunities & Trends in Global Market
Table 2. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers in Global Market
Table 3. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints in Global Market
Table 4. Key Players of Autologous Stem Cell and Non-Stem Cell Based Therapies in Global Market
Table 5. Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Share by Companies, 2018-2023
Table 8. Global Companies Autologous Stem Cell and Non-Stem Cell Based Therapies Product Type
Table 9. List of Global Tier 1 Autologous Stem Cell and Non-Stem Cell Based Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Stem Cell and Non-Stem Cell Based Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2024-2029
Table 30. Fibrocell Science, Inc. Company Summary
Table 31. Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 32. Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 33. Fibrocell Science, Inc. Key News & Latest Developments
Table 34. Vericel Corporation Company Summary
Table 35. Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 36. Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 37. Vericel Corporation Key News & Latest Developments
Table 38. Dendreon Corporation (Sanpower Group) Company Summary
Table 39. Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 40. Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 41. Dendreon Corporation (Sanpower Group) Key News & Latest Developments
Table 42. Caladrius Biosciences, Inc. Company Summary
Table 43. Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 44. Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 45. Caladrius Biosciences, Inc. Key News & Latest Developments
Table 46. BrainStorm Cell Therapeutics Company Summary
Table 47. BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 48. BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 49. BrainStorm Cell Therapeutics Key News & Latest Developments
Table 50. Regeneus Ltd. Company Summary
Table 51. Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 52. Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 53. Regeneus Ltd. Key News & Latest Developments
Table 54. Genzyme Corporation Company Summary
Table 55. Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 56. Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 57. Genzyme Corporation Key News & Latest Developments
Table 58. Pluristem Therapeutics Inc Company Summary
Table 59. Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 60. Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 61. Pluristem Therapeutics Inc Key News & Latest Developments
Table 62. U.S. Stem Cell, Inc Company Summary
Table 63. U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 64. U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 65. U.S. Stem Cell, Inc Key News & Latest Developments
Table 66. TiGenix (Takeda) Company Summary
Table 67. TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Product Offerings
Table 68. TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (US$, Mn) & (2018-2023)
Table 69. TiGenix (Takeda) Key News & Latest Developments
List of Figures
Figure 1. Autologous Stem Cell and Non-Stem Cell Based Therapies Segment by Type in 2022
Figure 2. Autologous Stem Cell and Non-Stem Cell Based Therapies Segment by Application in 2022
Figure 3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2022
Figure 8. By Type - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 9. By Application - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 10. By Type - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 12. By Application - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 14. By Region - Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 15. By Country - North America Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 16. US Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 20. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 21. France Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 28. China Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 32. India Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 34. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share, 2018-2029
Figure 37. Turkey Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue, (US$, Mn), 2018-2029
Figure 41. Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
